21 Sep 2010 10:58
| ||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
|
| |||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Source BioScience plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | X | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||
An event changing the breakdown of voting rights |
| |||
Other (please specify): |
|
| ||
3. Full name of person(s) subject to the notification obligation: iii | Aberforth Partners LLP | |||
4. Full name of shareholder(s) (if different from 3.):iv | 1. Aberforth Smaller Companies Trust plc - 7,516,000 2. Aberforth UK Small Companies Fund - 2,487,500 | |||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 8 September 2010 | |||
6. Date on which issuer notified: | 9 September 2010 | |||
7. Threshold(s) that is/are crossed or reached: vi, vii | 5% | |||
8. Notified details: | ||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||
GB0009739649 | 18,336,400 | 18,336,400 | 10,003,500 | N/A | 10,003,500 | N/A | 4.91 | |||||
| ||||||||||||
| ||||||||||||
B: Qualifying Financial Instruments | ||||||||||||
Resulting situation after the triggering transaction | ||||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||
N\A | N\A | N\A | N\A | N\A | ||||||||
| ||||||||||||
| ||||||||||||
Total (A+B+C) | ||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||
10,003,500 | 4.91% | |||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
Held by Aberforth Partners LLP | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | N|A | |
11. Number of voting rights proxy holder will cease to hold: | N|A | |
12. Date on which proxy holder will cease to hold voting rights: | N|A | |
| ||
13. Additional information: |
| |
14. Contact name: | Pauline Robson, Aberforth Partners LLP | |
15. Contact telephone number: | 0131 220 0733 | |
Note: Annex should only be submitted to the FSA not the issuer | |
Annex: Notification of major interests in share | |
| |
A: Identity of the persons or legal entity subject to the notification obligation | |
Full name (including legal form of legal entities)
| Aberforth Partners LLP |
Contact address (registered office for legal entities)
| 14 Melville Road, Edinburgh, EH3 7NS |
Phone number & email
| Pauline Robson - 0131 220 0733 |
Other useful information (at least legal representative for legal persons)
|
|
|
|
B: Identity of the notifier, if applicable | |
Full name
| Source BioScience plc |
Contact address
| 1 Orchard Place, Nottingham, NG8 6PX |
Phone number & email
| 0115 973 9010 |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
| |
C: Additional information | |
| |
|